» Articles » PMID: 8790036

Arrhythmogenic Right Ventricular Cardiomyopathy. Dysplasia, Dystrophy, or Myocarditis?

Overview
Journal Circulation
Date 1996 Sep 1
PMID 8790036
Citations 232
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a frequent cause of sudden death in young individuals and athletes. Although familial occurrence has been documented and a gene defect was recently localized on chromosome 14q23-q24 the etiopathogenesis of the disease is still obscure.

Methods And Results: A pathological study was conducted in 30 hearts with ARVC (age range, 15 to 65 years; mean, 28 years). In the 27 autopsy cases, the mode of death was sudden in 24 and congestive heart failure in 3. ECG, available in 19 cases, showed inverted T waves in the right precordial leads in 15 cases (79%) and ventricular arrhythmias in 15 (79%). Right ventricular aneurysms were present in 15 hearts (50%) and located in the inferior wall in 12. Left ventricle and ventricular septum were involved in 14 (47%) and 6 (20%) cases, respectively. Scattered foci of lymphocytes with myocardial death were observed in 20 cases (67%). Electron microscopy studies, although confirming the myocardial death and lymphocyte infiltrates, did not show any specific ultrastructural substrate. Two pathological patterns, fatty (40%) and fibrofatty (60%), were identified. The fibrofatty pattern was associated with a thinner right ventricular wall (P < .0001) and a higher occurrence of focal myocarditis (P < .001). In sections of right ventricular free wall with maximal fatty infiltration, the mean percentage area of fatty tissue was 35.9 +/- 11.1% in control versus 80.4 +/- 9.6% in the ARVC, fatty variety (P < .00001). Involvement of the left ventricle and/or ventricular septum, right ventricular aneurysms, and inflammation were found almost exclusively in the fibrofatty variety.

Conclusions: In the fibrofatty variety of ARVC, the myocardial atrophy appears to be the consequence of acquired injury (myocyte death) and repair (fibrofatty replacement), mediated by patchy myocarditis. Whether the inflammation is a primary event or a reaction to spontaneous cell death remains unclear.

Citing Articles

Arrhythmogenic Right Ventricular Cardiomyopathy: A Comprehensive Review.

Shaikh T, Nguyen D, Dugal J, DiCaro M, Yee B, Houshmand N J Cardiovasc Dev Dis. 2025; 12(2).

PMID: 39997505 PMC: 11855979. DOI: 10.3390/jcdd12020071.


The 'Padua classification' of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic.

Corrado D, Graziano F, Bauce B, Bueno Marinas M, Calore C, Celeghin R Eur Heart J Suppl. 2025; 27(Suppl 1):i73-i82.

PMID: 39980775 PMC: 11836707. DOI: 10.1093/eurheartjsupp/suae108.


Acute Myocarditis and Inflammatory Cardiomyopathies: Insights From Cardiac Magnetic Resonance Findings.

Lauriero F, Vita C, Perazzolo A, Sanseverino G, Moliterno E, Rovere G Echocardiography. 2025; 42(2):e70099.

PMID: 39963997 PMC: 11834149. DOI: 10.1111/echo.70099.


Arrhythmogenic left ventricular cardiomyopathy mimicking acute myocardial infarction.

Wu C, Zhou L, Wang X, Zu L, Xu W J Geriatr Cardiol. 2025; 21(12):1141-1146.

PMID: 39935439 PMC: 11808489. DOI: 10.26599/1671-5411.2024.12.004.


Naxos Disease and Related Cardio-Cutaneous Syndromes.

Protonotarios A, Asimaki A, Basso C, Xylouri Z, Monda E, Protonotarios I JACC Adv. 2025; 4(2):101547.

PMID: 39877668 PMC: 11773020. DOI: 10.1016/j.jacadv.2024.101547.